BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 17673327)

  • 1. Expression of human leucocyte antigen G (HLA-G) is associated with prognosis in non-small cell lung cancer.
    Yie SM; Yang H; Ye SR; Li K; Dong DD; Lin XM
    Lung Cancer; 2007 Nov; 58(2):267-74. PubMed ID: 17673327
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of human leukocyte antigen G (HLA-G) correlates with poor prognosis in gastric carcinoma.
    Yie SM; Yang H; Ye SR; Li K; Dong DD; Lin XM
    Ann Surg Oncol; 2007 Oct; 14(10):2721-9. PubMed ID: 17564748
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression and prognostic significance of cyclin B1 and cyclin A in non-small cell lung cancer.
    Cooper WA; Kohonen-Corish MR; McCaughan B; Kennedy C; Sutherland RL; Lee CS
    Histopathology; 2009 Jul; 55(1):28-36. PubMed ID: 19614764
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of HLA-G is associated with prognosis in esophageal squamous cell carcinoma.
    Yie SM; Yang H; Ye SR; Li K; Dong DD; Lin XM
    Am J Clin Pathol; 2007 Dec; 128(6):1002-9. PubMed ID: 18024326
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumour cell expression of C4.4A, a structural homologue of the urokinase receptor, correlates with poor prognosis in non-small cell lung cancer.
    Hansen LV; Skov BG; Ploug M; Pappot H
    Lung Cancer; 2007 Nov; 58(2):260-6. PubMed ID: 17706320
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overexpression of Pokemon in non-small cell lung cancer and foreshowing tumor biological behavior as well as clinical results.
    Zhao ZH; Wang SF; Yu L; Wang J; Chang H; Yan WL; Zhang J; Fu K
    Lung Cancer; 2008 Oct; 62(1):113-9. PubMed ID: 18550205
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevated expression of carcinoembryonic antigen-related cell adhesion molecule 1 (CEACAM-1) is associated with increased angiogenic potential in non-small-cell lung cancer.
    Dango S; Sienel W; Schreiber M; Stremmel C; Kirschbaum A; Pantel K; Passlick B
    Lung Cancer; 2008 Jun; 60(3):426-33. PubMed ID: 18215438
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Centromere protein H is a novel prognostic marker for human nonsmall cell lung cancer progression and overall patient survival.
    Liao WT; Wang X; Xu LH; Kong QL; Yu CP; Li MZ; Shi L; Zeng MS; Song LB
    Cancer; 2009 Apr; 115(7):1507-17. PubMed ID: 19170237
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is downregulation of MHC class I antigen expression in human non-small cell lung cancer associated with prolonged survival?
    Ramnath N; Tan D; Li Q; Hylander BL; Bogner P; Ryes L; Ferrone S
    Cancer Immunol Immunother; 2006 Aug; 55(8):891-9. PubMed ID: 16187081
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HLA-F expression is a prognostic factor in patients with non-small-cell lung cancer.
    Lin A; Zhang X; Ruan YY; Wang Q; Zhou WJ; Yan WH
    Lung Cancer; 2011 Dec; 74(3):504-9. PubMed ID: 21561677
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevated expression of carcinoembryonic antigen-related cell adhesion molecule 1 promotes progression of non-small cell lung cancer.
    Sienel W; Dango S; Woelfle U; Morresi-Hauf A; Wagener C; Brümmer J; Mutschler W; Passlick B; Pantel K
    Clin Cancer Res; 2003 Jun; 9(6):2260-6. PubMed ID: 12796394
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic significance of immunohistochemical Rac1 expression in survival in early operable non-small cell lung cancer.
    Yuan K; Qian C; Zheng R
    Med Sci Monit; 2009 Nov; 15(11):BR313-9. PubMed ID: 19865048
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic effect of epithelial and stromal lymphocyte infiltration in non-small cell lung cancer.
    Al-Shibli KI; Donnem T; Al-Saad S; Persson M; Bremnes RM; Busund LT
    Clin Cancer Res; 2008 Aug; 14(16):5220-7. PubMed ID: 18698040
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic relevance of soluble human leukocyte antigen-G and total human leukocyte antigen class I molecules in lung cancer patients.
    Schütt P; Schütt B; Switala M; Bauer S; Stamatis G; Opalka B; Eberhardt W; Schuler M; Horn PA; Rebmann V
    Hum Immunol; 2010 May; 71(5):489-95. PubMed ID: 20156510
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Influence of overexpressed coagulant and fibrolytic components in tumor tissues on the prognosis of non-small cell lung cancer].
    Chen WH; Wang C; Zhang YH; Yang YH; Zhan HY; Zhang LM
    Zhonghua Yi Xue Za Zhi; 2007 Dec; 87(45):3228-32. PubMed ID: 18399120
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic value of circulating chromogranin A and soluble tumor necrosis factor receptors in advanced nonsmall cell lung cancer.
    Gregorc V; Spreafico A; Floriani I; Colombo B; Ludovini V; Pistola L; Bellezza G; Viganò MG; Villa E; Corti A
    Cancer; 2007 Aug; 110(4):845-53. PubMed ID: 17599769
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Tissue array analysis of the aberrant expression of HLA class I molecules in human non small cell lung cancer].
    Suzuki H; Higuchi M; Hasegawa T; Yonechi A; Ohsugi J; Yamada F; Hoshino M; Shio Y; Fujiu K; Gotoh M
    Gan To Kagaku Ryoho; 2006 Nov; 33(12):1713-6. PubMed ID: 17212084
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of transforming acidic coiled-coil containing protein 3 is a novel independent prognostic marker in non-small cell lung cancer.
    Jung CK; Jung JH; Park GS; Lee A; Kang CS; Lee KY
    Pathol Int; 2006 Sep; 56(9):503-9. PubMed ID: 16930330
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical significance of HLA class I alleles on postoperative prognosis of lung cancer patients in Japan.
    Nagata Y; Hanagiri T; Mizukami M; Kuroda K; Shigematsu Y; Baba T; Ichiki Y; Yasuda M; So T; Takenoyama M; Sugio K; Nagashima A; Yasumoto K
    Lung Cancer; 2009 Jul; 65(1):91-7. PubMed ID: 19054590
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased expression of collagen XVIII and its prognostic value in nonsmall cell lung carcinoma.
    Chang H; Iizasa T; Shibuya K; Iyoda A; Suzuki M; Moriya Y; Liu TL; Hiwasa T; Hiroshima K; Fujisawa T
    Cancer; 2004 Apr; 100(8):1665-72. PubMed ID: 15073855
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.